A gene signature associated with prognosis and immune processes in head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

A gene signature associated with prognosis and immune processes in head and neck squamous cell carcinoma

Published:2019-03-06 Issue:8 Volume:41 Page:2581-2590
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head & Neck

Author:

Bai Shuang¹,Zhang Ping¹,Zhang Jian-Cheng¹,Shen Jun¹,Xiang Xu¹,Yan Ying-Bin¹,Xu Zhen-Qi¹,Zhang Jun¹,Long Li¹,Wang Chao¹,Shi Ping¹,Yang Li¹,Chen Wei¹,Liu Hao¹^ORCID

Affiliation:

1. Department of Oral and Maxillofacial Surgery; Stomatological Hospital of Nankai University, Tianjin Stomatological Hospital; Tianjin China

Publisher

Wiley

Subject

Otorhinolaryngology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hed.25731/fullpdf

Reference48 articles.

1. Head and neck cancer;Vokes;N Engl J Med,1993

2. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths;Siegel;CA Cancer J Clin,2011

3. AJCC Cancer Staging Manual

4. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer;Posner;N Engl J Med,2007

5. Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy;Vermorken;J Clin Oncol,2007

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular subtyping of head and neck cancer – Clinical applicability and correlations with morphological characteristics;Oral Oncology;2024-02

2. The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: Robust gene signature correlates with radiotherapy outcome in patients and xenografts;Radiotherapy and Oncology;2024-02

3. Identification of lysosome-related genes in connection with prognosis and immune cell infiltration for drug candidates in head and neck cancer;Open Life Sciences;2023-01-01

4. Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC;Scientific Reports;2022-10-06

5. A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT;Cancers;2022-06-20